{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T19:58:01Z","timestamp":1780084681688,"version":"3.54.0"},"reference-count":35,"publisher":"Bentham Science Publishers Ltd.","issue":"2","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["EMIDDT"],"published-print":{"date-parts":[[2021,2,12]]},"abstract":"<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p>Endothelial nitric oxide synthase (eNOS) plays a major role in the response of\nanti-hypercholesterol statin drugs. Genetic polymorphisms in the eNOS gene affect the activity of\neNOS thereby modulating the statin response.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Objectives:<\/jats:title>\n<jats:p>This study investigated the influence of major functional eNOS gene polymorphisms\n(rs2070744, rs1799983, and rs61722009) on the lipid profile of type 2 diabetes mellitus (T2DM) Jordanian\npatients treated with atorvastatin.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods:<\/jats:title>\n<jats:p>The sample comprised 103 T2DM patients who attended the diabetes clinic of Jordan University\nHospital. The T2DM patients had regularly been taking 20 mg atorvastatin. The atorvastatin\nresponse was calculated by measuring the lipid profile before and after three months of atorvastatin\ntreatment. The eNOS genotypes of the subjects were analyzed using polymerase chain reaction (PCR)\nfollowed by restriction fragment length polymorphism (RFLP) assay.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p>No significant association was found between eNOS genetic polymorphisms and the response\nto atorvastatin (ANOVA, p &gt; 0.05). In addition, no significant difference in the frequency of eNOS\ngenotypes was found between T2DM patients and healthy subjects. However, patients with eNOS\nrs1799983, 4a\/4a, and rs61722009 G\/G genotypes showed significantly lower levels of baseline total\ncholesterol (TC) and low density lipoprotein (LDL) than did patients carrying the rs1799983 4b\/4b or\nrs61722009 T\/T genotype (p &lt; 0.05). The eNOS rs1799983 and rs61722009 polymorphisms were in\ncomplete linkage disequilibrium (D' = 1).<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>Although no association was found between eNOS genetic polymorphisms and atorvastatin\nresponse, there was a significant association between the rs1799983 and rs61722009 genotypes\nand baselines levels of TC and LDL in Jordanian T2DM patients. These genetic variants affect cholesterol\nlevels and may play a role in the susceptibility to cardiovascular diseases in T2DM patients. Further\nstudies are needed to validate these findings.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1871530320666200621174858","type":"journal-article","created":{"date-parts":[[2020,6,22]],"date-time":"2020-06-22T07:52:21Z","timestamp":1592812341000},"page":"352-359","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["The Influence of Endothelial Nitric Oxide Synthase (eNOS) Genetic Polymorphisms on Cholesterol Blood Levels Among Type 2 Diabetic Patients on Atorvastatin Therapy"],"prefix":"10.2174","volume":"21","author":[{"given":"Sarah","family":"Abdullah","sequence":"first","affiliation":[{"name":"Department of Pharmacology, Faculty of Medicine, University of Jordan, Amman,Jordan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yazun","family":"Jarrar","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Science, Faculty of Pharmacy, Al-Zaytoonah University of Jordan, Amman,Jordan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hussam","family":"Alhawari","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Faculty of Medicine, University of Jordan, Amman,Jordan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eyada","family":"Abed","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Faculty of Medicine, University of Jordan, Amman,Jordan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malek","family":"Zihlif","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Faculty of Medicine, University of Jordan, Amman,Jordan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"S10","DOI":"10.1016\/j.jcjd.2017.10.003","volume":"42","author":"Punthakee Z.","year":"2018","unstructured":"Punthakee Z.; Goldenberg R.; Katz P.; Definition, classification and diagnosis of diabetes, prediabetes and metabolic syndrome. Can J Diabetes 2018,42(Suppl. 1),S10-S15","journal-title":"Can J Diabetes"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"S13","DOI":"10.2337\/dc19-S002","volume":"42","year":"2019","unstructured":"2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2019. Diabetes Care American Diabetes Association2019,42(Suppl. 1),S13-S28","journal-title":"Diabetes Care"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"S68","DOI":"10.2337\/diacare.27.2007.S68","volume":"27","author":"Haffner S.M.","year":"2004","unstructured":"Haffner S.M.; American Diabetes Association. Dyslipidemia management in adults with diabetes. Diabetes Care 2004,27(Suppl. 1),S68-S71","journal-title":"Diabetes Care"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1038\/sj.jhh.1002058","volume":"20","author":"Jessani S.","year":"2006","unstructured":"Jessani S.; Watson T.; Cappuccio F.P.; Lip G.Y.; Prevention of cardiovascular disease in clinical practice: The Joint British Societies\u2019 (JBS 2) guidelines. J Hum Hypertens 2006,20(9),641-645","journal-title":"J Hum Hypertens"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1007\/s13300-016-0167-x","volume":"7","author":"Schofield J.D.","year":"2016","unstructured":"Schofield J.D.; Liu Y.; Rao-Balakrishna P.; Malik R.A.; Soran H.; Diabetes dyslipidemia. Diabetes Ther 2016,7(2),203-219","journal-title":"Diabetes Ther"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s40256-019-00391-z","volume":"20","author":"Nesti L.","year":"2019","unstructured":"Nesti L.; Mengozzi A.; Natali A.; Statins, LDL cholesterol control, cardiovascular disease prevention, and atherosclerosis progression: a clinical perspective. Am J Cardiovasc Drugs 2019,20(5),1-8","journal-title":"Am J Cardiovasc Drugs"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1161\/01.CIR.97.12.1129","volume":"97","author":"Laufs U.","year":"1998","unstructured":"Laufs U.; La Fata V.; Plutzky J.; Liao J.K.; Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors. Circulation 1998,97(12),1129-1135","journal-title":"Circulation"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1017\/S0007114510001145","volume":"104","author":"Freitas R.N.","year":"2010","unstructured":"Freitas R.N.; Khaw K-T.; Wu K.; Bowman R.; Jeffery H.; Luben R.; Wareham N.J.; Bingham S.A.; A single nucleotide polymorphism in the 3-hydroxy-3-methylglutaryl-coenzyme A reductase gene (HMGCR) influences the serum triacylglycerol relationship with dietary fat and fibre in the European prospective investigation into cancer and nutrition in Norfolk (EPIC-Norfolk) study. Br J Nutr 2010,104(5),765-772","journal-title":"Br J Nutr"},{"key":"ref=9","doi-asserted-by":"publisher","DOI":"10.1016\/j.biocel.2020.105735","volume":"122","author":"Liberale L.","year":"2020","unstructured":"Liberale L.; Carbone F.; Montecucco F.; Sahebkar A.; Statins reduce vascular inflammation in atherogenesis: a review of underlying molecular mechanisms. Int J Biochem Cell Biol 2020,122","journal-title":"Int J Biochem Cell Biol"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1017\/S0007114510001145","volume":"104","author":"Freitas R.N.","year":"2010","unstructured":"Freitas R.N.; Khaw K.; Wu K.; Bowman R.; Jeffery H.; Luben R.; Wareham N.J.; Bingham S.A.; A single nucleotide polymorphism in the 3-hydroxy-3-methylglutaryl-coenzyme a reductase gene (HMGCR) influences the serum triacylglycerol relationship with dietary fat and fibre in the European prospective investigation into cancer and nutrition in Norfolk (EPIC-Norfolk) study, 2010,104(5),765-772"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.2217\/pgs-2018-0098","volume":"19","author":"Luizon M.R.","year":"2018","unstructured":"Luizon M.R.; Pereira D.A.; Tanus-Santos J.E.; Pharmacogenetic relevance of endothelial nitric oxide synthase polymorphisms and gene interactions. Pharmacogenomics 2018,19(18),1423-1435","journal-title":"Pharmacogenomics"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"23","DOI":"10.2310\/JIM.0b013e3181c6197f","volume":"58","author":"Sinici I.","year":"2010","unstructured":"Sinici I.; Atalar E.; Kepez A.; Hayran M.; Aksoyek S.; Tokgozoglu L.; Ozmen F.; Intron 4 VNTR polymorphism of eNOS gene is protective for cardiac syndrome X. J Investig Med 2010,58(1),23-27","journal-title":"J Investig Med"},{"key":"ref=13","first-page":"6","volume":"5","author":"Bhutani N.","year":"2020","unstructured":"Bhutani N.; Tangadi D.; Bhavsar P.; Role of endothelial nitric oxide synthase (T-786C) gene polymorphism in the development of coronary artery disease. Galore Int J Health Sci Res 2020,5(1),6-12","journal-title":"Galore Int J Health Sci Res"},{"key":"ref=14","doi-asserted-by":"publisher","DOI":"10.1080\/19932820.2017.1408381","volume":"13","author":"Jarrar Y.B.","year":"2018","unstructured":"Jarrar Y.B.; Balasmeh A.A.; Jarrar W.; Sequence analysis of the N-acetyltransferase 2 gene (NAT2) among Jordanian volunteers. Libyan J Med 2018,13(1)","journal-title":"Libyan J Med"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13007-016-0152-4","volume":"13","author":"Abdel-Latif A.","year":"2017","unstructured":"Abdel-Latif A.; Osman G.; Comparison of three genomic DNA extraction methods to obtain high DNA quality from maize. Plant Methods 2017,13(1),1-9","journal-title":"Plant Methods"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1097\/MBC.0b013e328346ef71","volume":"22","author":"Elshamaa M.F.","year":"2011","unstructured":"Elshamaa M.F.; Sabry S.; Badr A.; El-Ahmady M.; Elghoroury E.A.; Thabet E.H.; Kandil D.; Kamel S.; Endothelial nitric oxide synthase gene intron4 VNTR polymorphism in patients with chronic kidney disease. Blood Coagul Fibrinolysis 2011,22(6),487-492","journal-title":"Blood Coagul Fibrinolysis"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1007\/s00228-008-0602-7","volume":"65","author":"Nagassaki S.","year":"2009","unstructured":"Nagassaki S.; Herculano R.D.; Graeff C.F.O.; Tanus-Santos J.E.; eNOS T-786C polymorphism affects atorvastatin-induced changes in erythrocyte membrane fluidity. Eur J Clin Pharmacol 2009,65(4),385-392","journal-title":"Eur J Clin Pharmacol"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"6719","DOI":"10.1007\/s11033-014-3557-z","volume":"41","author":"Jamil K.","year":"2014","unstructured":"Jamil K.; Kandula V.; Kandula R.; Asimuddin M.; Joshi S.; Yerra S.K.; Polymorphism of CYP3A4 2 and eNOS genes in the diabetic patients with hyperlipidemia undergoing statin treatment. Mol Biol Rep 2014,41(10),6719-6727","journal-title":"Mol Biol Rep"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"2451","DOI":"10.1001\/jama.2013.281348","volume":"310","author":"Taylor F.C.","year":"2013","unstructured":"Taylor F.C.; Huffman M.; Ebrahim S.; Statin therapy for primary prevention of cardiovascular disease. JAMA 2013,310(22),2451-2452","journal-title":"JAMA"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1111\/j.1742-7843.2010.00551.x","volume":"106","author":"Lacchini R.","year":"2010","unstructured":"Lacchini R.; Silva P.S.; Tanus-Santos J.E.; A pharmacogenetics-based approach to reduce cardiovascular mortality with the prophylactic use of statins. Basic Clin Pharmacol Toxicol 2010,106(5),357-361","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/j.atherosclerosis.2006.07.020","volume":"193","author":"Souza-Costa D.C.","year":"2007","unstructured":"Souza-Costa D.C.; Sandrim V.C.; Lopes L.F.; Gerlach R.F.; Rego E.M.; Tanus-Santos J.E.; Anti-inflammatory effects of atorvastatin: modulation by the T-786C polymorphism in the endothelial nitric oxide synthase gene. Atherosclerosis 2007,193(2),438-444","journal-title":"Atherosclerosis"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1016\/j.freeradbiomed.2006.04.026","volume":"41","author":"Nagassaki S.","year":"2006","unstructured":"Nagassaki S.; Sert\u00f3rio J.T.; Metzger I.F.; Bem A.F.; Rocha J.B.; Tanus-Santos J.E.; eNOS gene T-786C polymorphism modulates atorvastatin-induced increase in blood nitrite. Free Radic Biol Med 2006,41(7),1044-1049","journal-title":"Free Radic Biol Med"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1097\/01213011-200505000-00008","volume":"15","author":"Abe K.","year":"2005","unstructured":"Abe K.; Nakayama M.; Yoshimura M.; Nakamura S.; Ito T.; Yamamuro M.; Sakamoto T.; Miyamoto Y.; Yoshimasa Y.; Saito Y.; Nakao K.; Yasue H.; Ogawa H.; Increase in the transcriptional activity of the endothelial nitric oxide synthase gene with fluvastatin: a relation with the -786T>C polymorphism. Pharmacogenet Genomics 2005,15(5),329-336","journal-title":"Pharmacogenet Genomics"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.niox.2013.07.005","volume":"33","author":"Andrade V.L.","year":"2013","unstructured":"Andrade V.L.; Sert\u00f3rio J.T.; Eleuterio N.M.; Tanus-Santos J.E.; Fernandes K.S.; Sandrim V.C.; Simvastatin treatment increases nitrite levels in obese women: modulation by T(-786)C polymorphism of eNOS. Nitric Oxide 2013,33,83-87","journal-title":"Nitric Oxide"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1590\/S0066-782X2012005000120","volume":"100","author":"Zago V.H.","year":"2013","unstructured":"Zago V.H.; Santos J.E.; Danelon M.R.; Silva R.M.; Panzoldo N.B.; Parra E.S.; Alexandre F.; Virg\u00ednio V.W.; Quint\u00e3o E.C.; Faria E.C.; Effects of atorvastatin and T-786C polymorphism of eNOS gene on plasma metabolic lipid parameters. Arq Bras Cardiol 2013,100(1),14-20","journal-title":"Arq Bras Cardiol"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1007\/s001099900020","volume":"77","author":"Cai H.","year":"1999","unstructured":"Cai H.; Wilcken D.E.; Wang X.L.; The Glu-298-->Asp (894G-->T) mutation at exon 7 of the endothelial nitric oxide synthase gene and coronary artery disease. J Mol Med (Berl) 1999,77(6),511-514","journal-title":"J Mol Med (Berl)"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1006\/mgme.2000.3033","volume":"70","author":"Wang X.L.","year":"2000","unstructured":"Wang X.L.; Wang J.; Endothelial nitric oxide synthase gene sequence variations and vascular disease. Mol Genet Metab 2000,70(4),241-251","journal-title":"Mol Genet Metab"},{"key":"ref=28","first-page":"13","volume":"3","author":"Syed R.","year":"2011","unstructured":"Syed R.; Biyabani M.U.; Prasad S.; Deeba F.; Jamil K.; Evidence of association of a common variant of the endothelial nitric oxide synthase gene (Glu 298\u2192 Asp polymorphism) to coronary artery disease in South Indian population. J Med Genet Genomics 2011,3,13-18","journal-title":"J Med Genet Genomics"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.1007\/s00439-012-1202-2","volume":"131","author":"Munshi A.","year":"2012","unstructured":"Munshi A.; Genetic variation in MDR1, LPL and eNOS genes and the response to atorvastatin treatment in ischemic stroke. Hum Genet 2012,131(11),1775-1781","journal-title":"Hum Genet"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1007\/s00109-002-0398-3","author":"Kunnas T. A.","year":"2002","unstructured":"Kunnas T. A.; Lehtim\u00e4ki T.; Laaksonen R.; Ilveskoski E.; Janatuinen T.; Vesalainen R.; Nuutila P.; Karhunen P. J.; Knuuti J.; Nikkari S. T.; Endothelial nitric oxide synthase genotype modulates the improvement of coronary blood flow by pravastatin: a placebo-controlled PET study 2002,802-807"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.atherosclerosis.2005.03.035","volume":"184","author":"Pereira A.C.","year":"2006","unstructured":"Pereira A.C.; Sposito A.C.; Mota G.F.; Cunha R.S.; Herkenhoff F.L.; Mill J.G.; Krieger J.E.; Endothelial nitric oxide synthase gene variant modulates the relationship between serum cholesterol levels and blood pressure in the general population: new evidence for a direct effect of lipids in arterial blood pressure. Atherosclerosis 2006,184(1),193-200","journal-title":"Atherosclerosis"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.ypmed.2008.04.006","volume":"47","author":"Sawada T.","year":"2008","unstructured":"Sawada T.; Kishimoto T.; Osaki Y.; Okamoto M.; Tahara A.; Kaetu A.; Kurosawa Y.; Kotani K.; Relation of the Glu298Asp polymorphism of the nitric oxide synthase gene to hypertension and serum cholesterol in Japanese workers. Prev Med 2008,47(2),167-171","journal-title":"Prev Med"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1159\/000045957","volume":"88","author":"Asanuma K.","year":"2001","unstructured":"Asanuma K.; Yokoyama K.; Tsukada T.; Takemoto F.; Hara S.; Yamada A.; Tomino Y.; An intron 4 gene polymorphism in endothelial cell nitric oxide synthase might modulate lipid metabolism in nondiabetic patients on hemodialysis. Nephron 2001,88(1),39-43","journal-title":"Nephron"},{"key":"ref=34","first-page":"47","volume":"51","author":"Milutinovi\u0107 A.","year":"2005","unstructured":"Milutinovi\u0107 A.; Hruskovicova H.; The eNOS gene polymorphism does not have a major impact on lipid parameters and premature coronary artery disease in Slovene men (Caucasians). Folia Biol (Praha) 2005,51(2),47-49","journal-title":"Folia Biol (Praha)"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/j.orcp.2015.04.008","volume":"10","author":"Nasr H.B.","year":"2016","unstructured":"Nasr H.B.; Dimassi S.; M\u2019hadhbi R.; Debbabi H.; Kortas M.; Tabka Z.; Chahed K.; Functional G894T (rs1799983) polymorphism and intron-4 VNTR variant of nitric oxide synthase (NOS3) gene are susceptibility biomarkers of obesity among Tunisians. Obes Res Clin Pract 2016,10(4),465-475","journal-title":"Obes Res Clin Pract"}],"container-title":["Endocrine, Metabolic &amp; Immune Disorders - Drug Targets"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/eurekaselect.com\/article\/download\/183003","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.eurekaselect.com\/183003\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/eurekaselect.com\/article\/download\/183003","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,2]],"date-time":"2022-01-02T14:51:48Z","timestamp":1641135108000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.eurekaselect.com\/183003\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,12]]},"references-count":35,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,2,12]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1871530320666200621174858","relation":{},"ISSN":["1871-5303"],"issn-type":[{"value":"1871-5303","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2,12]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2020-01-30","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-04-30","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-05-08","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-02-12","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}